Lv3
290 积分 2025-12-14 加入
Targeting B Cells and Plasma Cells in Glomerular Disease
3天前
已完结
A multi-institutional perspective on tarlatamab administration and management of CRS/ICANS
6天前
已完结
Reactions and adverse events induced by T-cell engagers as anti-cancer immunotherapies, a comprehensive review
6天前
已完结
T-cell engagers in rheumatology
6天前
已完结
OP0193 BITEING MULTI-DRUG RESISTANT RHEUMATOID ARTHRITIS WITH CD19-T CELL ENGAGERS
6天前
已关闭
CD19xCD3 T cell engager blinatumomab effective in refractory generalized myasthenic syndromes
6天前
已关闭
Application of blinatumomab, a bispecific anti-CD3/CD19 T-cell engager, in treating severe systemic sclerosis: A case study
6天前
已完结
Safety and efficacy of blinatumomab in the treatment of refractory systemic sclerosis: a case series
6天前
已完结
Bispecific T cell engager therapy for refractory rheumatoid arthritis
6天前
已完结
CD19-CAR T-cell therapy induces deep tissue depletion of B cells
6天前
已完结
皖公网安备34019202002308
